文献速递类风湿关节炎痛风与晶体性关节病

关节液钙卫蛋白可区分化脓性关节炎与假性痛风及类风湿关节炎

Calprotectin discriminates septic arthritis from pseudogout and rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

研究前瞻性收集以中性粒细胞为主的关节液,比较化脓性关节炎、假性痛风与类风湿关节炎患者关节液中钙卫蛋白和α-防御素水平。共纳入74例患者,多变量模型显示钙卫蛋白是唯一能区分化脓性与非化脓性炎性关节炎的生物标志物,阈值150 mg/l时敏感度76%、特异度94%、阳性似然比12.2。

要点

  • 关节液钙卫蛋白在化脓性关节炎中显著升高。
  • 钙卫蛋白150 mg/l阈值下区分化脓性与非化脓性炎性关节炎的敏感度76%、特异度94%。
  • 多变量模型纳入钙卫蛋白、关节液中性粒细胞计数和性别。

核心结论

  • 关节液钙卫蛋白是区分化脓性关节炎与其他炎性关节炎的相关生物标志物,需在独立队列中验证。

研究设计与样本

  • 前瞻性收集以中性粒细胞为主的关节液,纳入化脓性关节炎26例、假性痛风28例和类风湿关节炎20例,共74例患者。

主要发现

  • 化脓性关节炎患者更可能为男性、年轻且关节液中性粒细胞计数更高。
  • 钙卫蛋白在化脓性关节炎患者中显著升高。
  • 多变量模型纳入钙卫蛋白、关节液中性粒细胞计数和性别。
  • 钙卫蛋白是唯一能区分化脓性与非化脓性炎性关节炎的生物标志物,阈值150 mg/l时敏感度76%、特异度94%、阳性似然比12.2。

关键数值与推荐

  • 钙卫蛋白阈值150 mg/l时区分化脓性与非化脓性炎性关节炎的敏感度76%、特异度94%、阳性似然比12.2。

临床怎么用

  • 关节液钙卫蛋白检测有助于临床鉴别化脓性关节炎与其他炎性关节炎。

局限性

  • 研究仅纳入化脓性关节炎、假性痛风与类风湿关节炎患者,样本量有限,结论需独立队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to determine whether calprotectin and α-defensins could discriminate septic from other inflammatory arthritides. METHODS: Synovial fluids with a predominance of neutrophils from patients with septic arthritis, pseudogout and RA were prospectively collected. Neutrophil-related proteins calprotectin and human neutrophil α-defensins levels were assessed in synovial fluids. Demographic parameters and biomarkers with P-value ⩽0.05 for differentiating septic from non-septic arthritis were included in a multivariable model. Multivariable logistic regression with stepwise selection was performed to build the final combined model. RESULTS: A total of 74 patients were included: septic arthritis (n = 26), pseudogout (n = 28) and RA (n = 20). Patients with septic arthritis were more likely to be male and young, and to display higher synovial neutrophil count. Calprotectin was significantly increased in patients with septic arthritis. The multivariable model included calprotectin, synovial fluid neutrophil count and gender. Calprotectin was the only biomarker that discriminated septic arthritis from non-septic inflammatory arthritides, with 76% sensitivity, 94% specificity and a positive likelihood ratio = 12.2 at the threshold for calprotectin of 150 mg/l. CONCLUSION: Synovial fluid calprotectin is a relevant biomarker to discriminate septic arthritis from other inflammatory arthritides. This biomarker should be tested in an independent cohort.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Baillet A, Trocmé C, Romand X, et al. Calprotectin discriminates septic arthritis from pseudogout and rheumatoid arthritis. Rheumatology (Oxford). 2019. PMID: 30919904. doi:10.1093/rheumatology/kez098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。